Abstract:Quantum Dots (QDs) modified with branched Polyethylene Glycol-amine (6- or 8-arm PEG-amine) coupled with methoxy PEG (mPEG) hold great promise for in vivo biomedical applications due to a long half-life in blood and negligible toxicity. However, the potential risks regarding their concomitant prolonged co-incubation with cardiovascular and blood cells remains inconclusive. In the present study, the feasible, effective and convenient proliferating-restricted cell line models representing the circulatory system were established to investigate the cellular internalization followed by intracellular outcomes and resulting acute/sub-acute cytotoxicity of the 6-arm PEG-amine/mPEG QDs. We found a dose-, time- and cell type-dependent cellular uptake of the 6-arm PEG-amine/mPEG QDs, which was ten-fold lower compared to the traditional linear PEG-modified counterpart. The QDs entered cells via multiple endocytic pathways and were mostly preserved in Golgi apparatus for at least one week instead of degradation in lysosomes, resulting in a minimal acute cytotoxicity, which is much lower than other types of PEG-modified QDs previously reported. However, a sub-acute cytotoxicity of QDs were observed several days post exposure using the concentrations eliciting no-significant acute cytotoxic effects, which was associated with elevated ROS generation caused by QDs remained inside cells. Finally, a non-cytotoxic concentration of the QDs was identified at the sub-acute cytotoxic level. Our study provided important information for clinical translation of branched PEG-amine/mPEG QDs by elucidating the QDs-cell interactions and toxicity mechanism using the proliferation-restricted cell models representing circulatory system. What's more, we emphasized the indispensability of sub-acute cytotoxic effects in the whole biosafety evaluation process of nanomaterials like QDs.

Cellular uptake and viability switching in the properties of lipid coated carbon quantum dots for potential bioimaging and therapeutics

Cellular uptake and viability switch in the properties of lipid-coated carbon quantum dots for potential bioimaging and therapeutics

Carbon Dots of Different Composition and Surface Functionalization: Cytotoxicity Issues Relevant to Fluorescence Cell Imaging

Quantum dots decorated single walled carbon nanotubes for multimodal cellular imaging

Ln(III) Chelates-Functionalized Carbon Quantum Dots: Synthesis, Optical Studies and Multimodal Bioimaging Applications.

Carbon quantum dots in bioimaging and biomedicines

Recent Progress in the Development of Carbon Quantum Dots for Cell Imaging

Near-infrared emissive lanthanide hybridized carbon quantum dots for bioimaging applications.

Bioconjugated Quantum Dots for in Vivo Molecular and Cellular Imaging☆

Carbon quantum dots: A promising nanocarrier for bioimaging and drug delivery in cancer

Biomass-derived carbon dots as fluorescent quantum probes to visualize and modulate inflammation

Variable Cellular Conduct of Photonic Carbon Nano-Dots

Quantum dot probes for cellular analysis

Cellular uptake, intracellular behavior, and acute/sub-acute cytotoxicity of a PEG-modified quantum dot with promising in-vivo biomedical applications

Non-specific cellular uptake of surface-functionalized quantum dots

Luminescent carbon quantum dots and their application in cell imaging

Luminescent Carbon Quantum Dots Derived from Syzygium cumini Seeds with Endogenous Anti-Oxidant and Cytotoxic Potency including in vitro Photoluminescence and Live Cell Imaging

derived, red-emitting, carbon nanoparticles for cellular bioimaging and potential therapeutics

Assessment of the biocompatibility and bioimaging potential of fluorescent carbon dots derived from waste biomass

Fluorescent carbon quantum dots: Synthesis methods, functionalization and biomedical applications

Carbon “quantum” Dots for Fluorescence Labeling of Cells